Latest Period
Q2 2026
Security Snapshot
PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) Institutional Ownership
CUSIP: 74019P207
13F Institutional Holders and Ownership History from Q1 2024 to Q2 2026
Institutions Reporting
93
Shares (Excl. Options)
17,674,848
Price
$7.86
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.000005 per share
- Symbol
- DTIL on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 17,674,848
- Total 13F value
- $138,925,760
- Portfolio coverage rank
- 0%
- Share change
- +1,441,775
- Value change
- +$13,278,576
- Number of holders
- 93
- Shares outstanding
- 27,643,000
- SEC-reported price per share
- $7.00
- Insider filing price
- $7.00
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share is tracked under CUSIP 74019P207.
- 93 institutions reported positions in Q2 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 75 to 93 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $88,056,671 to $138,925,760.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 93 institutions filings for Q2 2026.
Security key
74019P207
Latest holder period
Q2 2026
13F holders
93
13D/G owners
9
CIK / CUSIP context first
Open Q2 2026 holders
DTIL full holder history
PRECISION BIOSCIENCES INC SEC filings
PRECISION BIOSCIENCES INC company facts
PRECISION BIOSCIENCES INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74019P207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
DTIL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 10% | $9,570,073 | 2,328,485 | Octagon Capital Advisors LP | 31 Dec 2025 | |||
| Aberdeen Group plc | 8.9% | $8,896,588 | 2,138,603 | Aberdeen Group plc | 31 Dec 2025 | |||
| Bleichroeder LP | 8.2% | -15% | $7,809,000 | +$3,390,750 | 1,900,000 | +77% | Bleichroeder LP | 31 Dec 2025 |
| Lynx1 Capital Management LP | 5.4% | +32% | $10,951,062 | +$3,123,997 | 1,390,611 | +40% | Lynx1 Capital Management LP | 13 Jul 2026 |
| Empery Asset Management, LP | 5% | -33% | $10,331,129 | -$5,144,260 | 1,314,393 | -33% | Empery Asset Management, LP | 30 Jun 2026 |
| Readout Capital, LP | 9.4% | +5.6% | $4,980,934 | +$829,645 | 1,119,311 | +20% | Matthew Smith | 30 Jun 2025 |
| Weinstein Benjamin | 4% | -24% | $7,740,040 | +$4,971,617 | 1,105,720 | +180% | Weinstein Benjamin | 21 Aug 2026 |
| NOVARTIS PHARMA AG | 3.7% | -34% | $1,840,435 | 413,581 | 0% | Novartis Pharma AG | 30 Jun 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3.7% | $2,165,312 | 406,250 | Highbridge Capital Management, LLC | 31 Mar 2025 |
As of 30 Jun 2026, 93 institutional investors reported holding 17,674,848 shares of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL). This represents 64% of the company’s total 27,643,000 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
59%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Aberdeen Group plc | 8.1% | 2,230,178 | 0% | 0.02% | $17,529,199 |
| Bleichroeder LP | 7.3% | 2,018,190 | +21% | 2.8% | $15,862,973 |
| Octagon Capital Advisors LP | 4.9% | 1,350,000 | -40% | 0.97% | $10,611,000 |
| BOOTHBAY FUND MANAGEMENT, LLC | 4.9% | 1,346,004 | +26% | 0.2% | $10,579,591 |
| BlackRock, Inc. | 4.2% | 1,172,873 | +487% | 0% | $9,218,782 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 1,116,241 | +23% | 0% | $8,773,654 |
| Lynx1 Capital Management LP | 3.4% | 950,466 | -3.5% | 0.86% | $7,470,663 |
| Driehaus Capital Management LLC | 3.4% | 946,707 | -4.9% | 0.04% | $7,441,117 |
| Empery Asset Management, LP | 2.8% | 776,093 | -61% | 7.1% | $6,100,091 |
| Affinity Asset Advisors, LLC | 2.3% | 646,576 | +8.1% | 0.25% | $5,082,087 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 620,981 | +116% | 0% | $4,882,639 |
| MACKENZIE FINANCIAL CORP | 1.7% | 480,997 | 0% | $3,780,636 | |
| STATE STREET CORP | 1.5% | 427,325 | +486% | 0% | $3,358,775 |
| ACADIAN ASSET MANAGEMENT LLC | 1.1% | 305,759 | +583% | 0% | $2,396,000 |
| ArrowMark Colorado Holdings LLC | 0.99% | 274,140 | +53% | 0.09% | $2,154,740 |
| Corient Private Wealth LP | 0.89% | 245,058 | 0% | 0% | $1,926,156 |
| TWO SIGMA INVESTMENTS, LP | 0.86% | 237,863 | -23% | 0% | $1,869,603 |
| NORTHERN TRUST CORP | 0.69% | 190,188 | +150% | 0% | $1,494,878 |
| JPMORGAN CHASE & CO | 0.65% | 180,452 | +2255550% | 0% | $1,429,179 |
| VANGUARD FIDUCIARY TRUST CO | 0.6% | 166,538 | +7% | 0% | $1,308,989 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.59% | 161,782 | 0% | $1,271,607 | |
| GOLDMAN SACHS GROUP INC | 0.51% | 139,828 | +252% | 0% | $1,099,048 |
| Squarepoint Ops LLC | 0.5% | 137,106 | +213% | 0% | $1,077,653 |
| MORGAN STANLEY | 0.47% | 130,536 | +6.8% | 0% | $1,026,012 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.42% | 115,929 | +2.9% | 0% | $911,200 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 17,674,848 | $138,925,760 | +$13,278,576 | $7.86 | 93 |
| 2026 Q1 | 16,006,452 | $88,056,671 | +$4,555,748 | $5.50 | 75 |
| 2025 Q4 | 15,096,207 | $62,794,720 | +$33,303,415 | $4.16 | 67 |
| 2025 Q3 | 4,649,562 | $25,664,758 | +$1,234,800 | $5.52 | 54 |
| 2025 Q2 | 4,437,938 | $18,638,020 | +$2,152,791 | $4.20 | 51 |
| 2025 Q1 | 3,786,321 | $18,062,451 | +$340,769 | $4.77 | 47 |
| 2024 Q4 | 3,859,340 | $14,708,103 | -$4,075,765 | $3.81 | 51 |
| 2024 Q3 | 3,323,629 | $29,812,914 | +$1,425,206 | $8.96 | 50 |
| 2024 Q2 | 3,161,323 | $30,774,875 | -$108,215 | $9.73 | 45 |
| 2024 Q1 | 3,155,622 | $42,757,614 | +$42,755,553 | $13.56 | 40 |